Since the U.S. funded research that led to the development of effective Ebola vaccines and treatments, there has been a significant advancement in the global response to emerging health threats. Various U.S. agencies, such as the National Institutes of Health, Biomedical Advanced Research and Development Authority, Department of Defense, and Administration for Strategic Preparedness and Response, invest hundreds of millions of dollars annually into research and development of medical countermeasures. This funding has been crucial in not only protecting frontline health care workers but also in providing lifesaving care to patients and containing outbreaks before they escalate and potentially reach U.S. shores.

While these agencies are not without flaws, as seen in the CDC’s response to domestic outbreaks like the Covid-19 pandemic, it is important to recognize the immense scientific and operational capacities they have built over the years. Reforms to streamline processes, improve responsiveness, and enhance transparency are necessary to ensure these agencies continue to effectively combat emerging health threats.

Criticism and punishment of these agencies for perceived overreach during crises like the Covid-19 pandemic are counterproductive. Instead of discarding the expertise and infrastructure that have been cultivated, it is essential to refine and strengthen the global health apparatus that has been instrumental in protecting Americans and millions worldwide.

Misguided proposals, such as the “eight-year pause on infectious disease research” suggested by some, are not feasible as infectious threats do not adhere to timelines. Stepping back from investing in critical areas like combating antimicrobial resistance and climate change-driven diseases will only hinder the U.S.’s readiness to respond to future health crises. It is crucial to continue investing in research and development to stay ahead of global health challenges.

The United States remains the largest funder and implementer of global health programs, and it must maintain this position regardless of political changes. Global pathogens do not recognize borders, and it is imperative for the U.S. to lead in global health initiatives to protect its citizens and the world population.

In conclusion, the U.S.-funded research has played a vital role in developing tools to combat emerging health threats. It is essential to support and strengthen the institutions and agencies that have the expertise and infrastructure to respond effectively to global health crises. By continuing to invest in research and development, the U.S. can maintain its leadership in global health and protect the population from future health challenges.